This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Dieter Beermann: Innovator in Pharmaceutical Delivery Systems
Introduction
Dieter Beermann is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work has implications for improving the efficacy and tolerability of medications.
Latest Patents
Dieter Beermann holds a patent for "Intramuscular injection forms of gyrase inhibitors." This patent details that Ciprofloxacin and related gyrase inhibitors are well-tolerated when administered intramuscularly. The invention involves an aqueous suspension of the betaine form with an approximate neutral pH value or an oily suspension of the betaine or its salts. The oily suspensions can release the active compound rapidly, especially when the wettability of the oily carrier medium is enhanced by adding interfacially surface-active materials.
Career Highlights
Dieter Beermann is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative solutions that enhance drug delivery methods. His contributions have been instrumental in advancing pharmaceutical technologies.
Collaborations
Dieter has collaborated with notable colleagues such as Norbert Pollinger and Peter Serno. These collaborations have fostered a productive environment for innovation and development in the pharmaceutical sector.
Conclusion
Dieter Beermann's work exemplifies the importance of innovation in the pharmaceutical industry. His patent on intramuscular injection forms of gyrase inhibitors showcases his commitment to improving drug delivery systems. His contributions continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
